Mitsui & Co. Global Investment mitsui-global.com

Mitsui & Co. Global Investment (MGI), formerly MVC Corporation, is a subsidiary of Mitsui & Co., Ltd., which invests in opportunities that have potential for growth. While they are headquartered in Tokyo, MGI also has offices in Silicon Valley, Beijing, Mumbai. Its investments reach beyond these geographical barriers, allows MGI to build a diversified global portfolio. MGI's investments are completely independent from its parent company's financial investments and do not have to be strategically...Show all

Mitsui & Co. Global Investment (MGI), formerly MVC Corporation, is a subsidiary of Mitsui & Co., Ltd., which invests in opportunities that have potential for growth. While they are headquartered in Tokyo, MGI also has offices in Silicon Valley, Beiji...Show all

See All Exits Recent Exits

Phone: +81-3-3285-3124

Fax:

Nikkei Bldg, 1-3-7, Otemachi
Chiyoda-ku
 Tokyo, 100-0004
 Japan

Mitsui & Co. Global Investment - Investments & Acquisitions

Show Real Data Mitsui & Co. Global Investment Investments
See all Recent Investments
Date Company Round Amount Co-investors
2020-05-13QurAlisSeries A$42MAmgen Ventures, Dementia Discovery Fund, Dolby Family Ventures, DROIA Ventures, INKEF Capital, Mission BioCapital, MP Healthcare Venture Management, Oxford Bioscience Partners, Polaris Partners, and Sanford Applied Biosciences
2020-04-13RallybioSeries B$145M5AM Ventures, Canaan Partners, Connecticut Innovations, F-Prime Capital, Fairview Capital Partners, New Leaf Venture Partners, Pivotal bioVenture Partners, Solasta Ventures, Tekla Capital Management, The Rise Fund, and Viking Global Investors
2019-09-25SpireSeries C - II$21.87MBessemer Venture Partners, Expon Capital, GPO Fund, ITOCHU Technology Ventures, Perennial Investors, Qualcomm Ventures, RRE Ventures, and Seraphim Capital
2019-05-07Promethera BiosciencesSeries D - II$32.64MCi:z Holdings, Korea Investment Partners, Medipal Holdings Corporation, Mirae Asset Capital, Shinsei Capital Partners, and Six Snow
2019-01-09NapaJen PharmaSeries C$12.4MInnovation Network Corporation of Japan, and P&D Directions
See all 5 investments